Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement activation in experimental human malaria infection.

Meta Roestenberg1, Matthew McCall, Tom Eirik Mollnes

  • 1Radboud University Nijmegen Medical Center, Postbus 9101, 6500 HB Nijmegen, The Netherlands. m.roestenberg@mmb.umcn.nl

Transactions of the Royal Society of Tropical Medicine and Hygiene
|May 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motivations and experiences in controlled human infection trials vs. phase I clinical trials: a survey study.

BMC medical ethics·2026
Same author

Refining the regulatory and ethics context of controlled human infection models - a stakeholder meeting report.

Biologicals : journal of the International Association of Biological Standardization·2026
Same author

Advances in vaccine development through the controlled human infection models for hookworm and schistosomiasis.

PLoS neglected tropical diseases·2026
Same author

Vaccine-induced mouse antibodies targeting Plasmodium falciparum PfVFT antigen inhibit blood stages through multiple mechanisms.

NPJ vaccines·2026
Same author

Robust Bioconjugated Antigens Induce Immune Responses Preventing Malaria Infection and its Transmission.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size.

Nature immunology·2026
Same journal

Acquired haemophilia B in Kyasanur Forest disease: a case series of isolated prolonged activated partial thromboplastin time.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2026
Same journal

Integrated and sustainable community approach to malaria prevention in Gulu District, Northern Uganda.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2026
Same journal

Long-lasting helminthic infection in African migrants to Israel - Lessons from the field.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2026
Same journal

Comment on: Impact of Wolbachia-infected Aedes aegypti on dengue incidence in endemic regions.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2026
Same journal

Bridging a critical gap in leishmaniasis control: focus on immature sandfly ecology.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2026
Same journal

Parents' challenges in identifying offending snakes during paediatric snakebites in Sri Lanka: a qualitative study.

Transactions of the Royal Society of Tropical Medicine and Hygiene·2026
See all related articles

Early malaria infection activates the complement system, indicated by increased terminal complement complex (TCC) levels even before parasites are microscopically visible. Artemether/lumefantrine treatment further boosted TCC via classical and alternative pathways.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Malariology

Background:

  • Malaria, caused by Plasmodium falciparum, is a significant global health challenge.
  • The role of the complement system in early-stage malaria remains incompletely understood.
  • Complement activation products can indicate immune responses during infection.

Purpose of the Study:

  • To investigate complement activation during the early, uncomplicated phases of human malaria.
  • To assess the impact of antimalarial treatment on complement activation pathways.

Main Methods:

  • Experimental infection of healthy volunteers with Plasmodium falciparum.
  • Monitoring of parasitemia and complement activation products, including soluble terminal complement complex (TCC).
  • In vitro studies to confirm complement activation by parasite cultures and assess pathway involvement (classical, alternative, mannan-binding lectin).

Related Experiment Videos

Main Results:

  • A significant increase in TCC was observed during blood-stage parasitemia, even before microscopic detection.
  • Complement activation, involving both classical and alternative pathways, increased following artemether/lumefantrine treatment.
  • In vitro studies confirmed complement activation by parasite cultures.
  • No evidence of mannan-binding lectin-mediated complement activation was found post-treatment.

Conclusions:

  • Complement activation occurs early in Plasmodium falciparum malaria, preceding detectable parasitemia.
  • Antimalarial treatment with artemether/lumefantrine modulates complement activation through classical and alternative pathways.
  • The study highlights the dynamic interplay between the parasite, the host immune system, and antimalarial drugs.